The Systemic Synuclein Sampling Study: Toward a Biomarker for Parkinson’s Disease
Authors:
- Naomi P VisanjiNVNaomi P Visanji
- Lana ChahineLCLana Chahine
- the Systemic Synuclein Sampling Study (S4)T(the Systemic Synuclein Sampling Study (S4)
Open Access
- 29 March 2017
- journal article
- research article
- Published by Taylor & Francis in Biomarkers in Medicine
- Vol. 11 (4) , 359-368
Abstract
The search for a biomarker for Parkinson's disease (PD) has led to a surge in literature describing peripheral α-synuclein (aSyn) in both biofluids and biopsy/autopsy tissues. Despite encouraging results, attempts to capitalize on this promise have fallen woefully short. The Systemic Synuclein Sampling Study (S4) is uniquely designed to identify a reproducible diagnostic and progression biomarker for PD. S4 will evaluate aSyn in multiple tissues and biofluids within the same subject and across the disease spectrum to identify the optimal biomarker source and provide vital information on the evolution of peripheral aSyn throughout the disease. Additionally, S4 will correlate the systemic aSyn profile with an objective measure of nigrostriatal dopaminergic function furthering our understanding of the pathophysiological progression of PD.Keywords
Funding Information
- Michael J Fox foundation for PD, NINDS PD Biospecimen Review Access Committee
- The University of Toronto McLaughlin Centre
- TEVA-Pharma, Desitin, Boehringer Ingelheim, GE Healthcare
- BMBF, EU, Deutsche Parkinson Vereinigung, Michael J Fox Foundation
- NIH, the Michael J Fox Foundation and the state of Arizona
- NIH, the Michael J Fox Foundation and serves on the Steering Committee
This publication has 57 references indexed in Scilit:
- Real-time quaking-induced conversionPrion, 2011
- Salivary α-synuclein and DJ-1: potential biomarkers for Parkinson's diseaseBrain, 2011
- Elevated Levels of α-Synuclein Oligomer in the Cerebrospinal Fluid of Drug-Naïve Patients with Parkinson's DiseaseJournal of Clinical Neurology, 2011
- The synaptic pathology of α-synuclein aggregation in dementia with Lewy bodies, Parkinson’s disease and Parkinson’s disease dementiaActa Neuropathologica, 2010
- Incidental Lewy body disease: Clinical comparison to a control cohortMovement Disorders, 2010
- Multi-organ distribution of phosphorylated α-synuclein histopathology in subjects with Lewy body disordersActa Neuropathologica, 2010
- Clinical availability of skin biopsy in the diagnosis of Parkinson's diseaseNeuroscience Letters, 2010
- Parkinson's DiseaseAnnals of the New York Academy of Sciences, 2009
- Unified staging system for Lewy body disorders: correlation with nigrostriatal degeneration, cognitive impairment and motor dysfunctionActa Neuropathologica, 2009
- α-Synuclein in filamentous inclusions of Lewy bodies from Parkinson’s disease and dementia with Lewy bodiesProceedings of the National Academy of Sciences, 1998